| 201 | ZLABZai Lab Ltd |
$460.2M |
-38.1% |
2025 |
| 202 | TARSTarsus Pharmaceuticals, Inc. |
$451.4M |
-14.7% |
2025 |
| 203 | AORTArtivion, Inc. |
$441.3M |
2.2% |
2025 |
| 204 | WGSGeneDx Holdings Corp. |
$427.5M |
-4.9% |
2025 |
| 205 | MDXGMimedx Group, Inc. |
$418.6M |
11.6% |
2025 |
| 206 | INVAInnoviva, Inc. |
$411.3M |
65.9% |
2025 |
| 207 | ARDXArdelyx, Inc. |
$407.3M |
-15.1% |
2025 |
| 208 | ARAYAccuray Inc |
$401.9M |
-12.2% |
2026 |
| 209 | IMCRImmunocore Holdings plc |
$400M |
-8.9% |
2025 |
| 210 | KRYSKrystal Biotech, Inc. |
$389.1M |
52.6% |
2025 |
| 211 | SNDASonida Senior Living, Inc. |
$381.1M |
-18.6% |
2025 |
| 212 | CDNACareDx, Inc. |
$379.8M |
-5.6% |
2025 |
| 213 | TWSTTwist Bioscience Corp |
$376.6M |
-20.6% |
2025 |
| 214 | PHARPharming Group N.V. |
$376.1M |
0.8% |
2025 |
| 215 | ARQTArcutis Biotherapeutics, Inc. |
$376.1M |
-4.3% |
2025 |
| 216 | INMDInMode Ltd. |
$370.5M |
25.3% |
2025 |
| 217 | MNKDMannkind Corp |
$349M |
1.7% |
2025 |
| 218 | INGNInogen Inc |
$348.7M |
-6.5% |
2025 |
| 219 | CSTLCastle Biosciences Inc |
$344.2M |
-7.0% |
2025 |
| 220 | ACBAurora Cannabis Inc |
CA$343.3M |
0.5% |
2025 |
| 221 | TCMDTactile Systems Technology Inc |
$329.5M |
5.8% |
2025 |
| 222 | FLGTFulgent Genetics, Inc. |
$322.7M |
-18.8% |
2025 |
| 223 | DCGODocGo Inc. |
$322.2M |
-56.6% |
2025 |
| 224 | ANGOAngiodynamics Inc |
$320.2M |
-11.5% |
2026 |
| 225 | CRMDCorMedix Inc. |
$311.7M |
52.3% |
2025 |
| 226 | PRCTPROCEPT BioRobotics Corp |
$308.1M |
-31.0% |
2025 |
| 227 | BLLNBillionToOne, Inc. |
$305.1M |
2.4% |
2025 |
| 228 | SKINSkinHealth Systems Inc. |
$300.8M |
-3.2% |
2025 |
| 229 | EOLSEvolus, Inc. |
$297.2M |
-17.4% |
2025 |
| 230 | IRWDIronwood Pharmaceuticals Inc |
$296.2M |
8.1% |
2025 |
| 231 | RIGLRigel Pharmaceuticals Inc |
$294.3M |
124.7% |
2025 |
| 232 | XERSXeris Biopharma Holdings, Inc. |
$291.8M |
0.2% |
2025 |
| 233 | AUPHAurinia Pharmaceuticals Inc. |
$283.1M |
101.5% |
2025 |
| 234 | ADPTAdaptive Biotechnologies Corp |
$277M |
-21.5% |
2025 |
| 235 | VCELVericel Corp |
$276.3M |
6.0% |
2025 |
| 236 | HROWHarrow, Inc. |
$272.3M |
-1.9% |
2025 |
| 237 | VMDViemed Healthcare, Inc. |
$270.3M |
5.5% |
2025 |
| 238 | IOVAIovance Biotherapeutics, Inc. |
$263.5M |
-148.4% |
2025 |
| 239 | ARVNArvinas, Inc. |
$262.6M |
-30.8% |
2025 |
| 240 | OMDAOmada Health, Inc. |
$260.2M |
-4.9% |
2025 |
| 241 | SDGRSchrodinger, Inc. |
$255.9M |
-40.4% |
2025 |
| 242 | LMATLemaitre Vascular Inc |
$249.6M |
23.1% |
2025 |
| 243 | RCUSArcus Biosciences, Inc. |
$247M |
-142.9% |
2025 |
| 244 | KROSKeros Therapeutics, Inc. |
$244.1M |
35.7% |
2025 |
| 245 | STAAStaar Surgical Co |
$239.4M |
-33.6% |
2025 |
| 246 | INCRIntercure Ltd. |
₪238.8M |
-28.4% |
2024 |
| 247 | KIDSOrthopediatrics Corp |
$236.3M |
-16.8% |
2025 |
| 248 | AKBAAkebia Therapeutics, Inc. |
$236.2M |
-2.3% |
2025 |
| 249 | ANABAnaptysbio, Inc |
$234.6M |
-5.6% |
2025 |
| 250 | CERSCerus Corp |
$233.8M |
-6.7% |
2025 |